Clinical safety and performance of the world's thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES - 1 study.

导出 LinkOut

翻译打印收藏纠错

作者： Sivaprasad,Kunjukrishnapilla ^[1] ; Jaspal,Arneja ^[2] ; Dilip,Kumar ^[3] ; Parneesh,Arora ^[4] ; Raghu R,Thagachagere ^[5] ; Manohar,Ganesan ^[6] ; Deepak,Davidson ^[7] ; Sanjeeb,Roy ^[8] ; Subhash,Chandra ^[9] ; Ashokkumar,Thakkar ^[10]

作者单位： Government TD Medical College, Vandanam, India. ^[1] Arneja Heart and Multispeciality Hospital, Nagpur, India. ^[2] Medica Superspecialty Hospital, Kolkata, India. ^[3] Fortis Hospital, Noida, India. ^[4] Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, India. ^[5] Fortis Malar Hospital, Chennai, India. ^[6] Caritas Hospital, Kottayam, India. ^[7] Fortis Hospital, Jaipur, India. ^[8] BLK Super Speciality Hospital, New Delhi, India. ^[9] Meril Life Sciences Pvt. Ltd., Vapi, India. ^[10]

DOI 10.4244/AIJ-D-24-00009

PMID 39347116

发布时间 2024-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

AsiaIntervention

2024年10卷3期

195-202页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical safety and performance of the world's thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES - 1 study.

AsiaIntervention

相似文献

AsiaIntervention

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical safety and performance of the world's thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES - 1 study.

AsiaIntervention

相似文献

AsiaIntervention

相关期刊

检索历史清除